Overall rank by patents
#19,290
of 49,997 tracked assignees
USPTO PatentsView assignee record - 15 granted patents across 7 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B26D (CUTTING; Details Common TO Machines FOR Perforating, Punching, Cutting-out, Stamping-out OR Severing).
The verdict
According to USPTO PatentsView, TVI ranks #19,290 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R19290 · Foreign Corporation #19,290 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Taheri LaDuca LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
TVI Entwicklung &… · this assignee
38 score
3D Lighting… · lowest
7 score
What this shows TVI's Innovation Score is 38.1/100 (top 42% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
TVI Entwicklung & Produktion GMBH is a focused PatentsView assignee: 7 CPC subclasses with 86.7% of grants classified under B26D (CUTTING; Details Common TO Machines FOR Perforating, Punching, Cutting-out, Stamping-out OR Severing). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2018. By volume, TVI sits between Transseptal Solutions Ltd. and Taiwan RedEye Biomedical Inc..
TVI Entwicklung & Produktion GMBH shows 8 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Transseptal Solutions Ltd.
15 patents
TRI Innovations, LLC
15 patents
Truox, Inc.
15 patents
Tunego, Inc.
15 patents
TVU Networks Corporation
15 patents
Ty-crop Manufacturing Ltd.
15 patents
Taheri LaDuca LLC
15 patents
Taiwan RedEye Biomedical Inc.
15 patents
TVI Entwicklung & Produktion GMBH
15 patents
What this shows TVI holds 15 patents at rank #19,248, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #19,248 in granted patent volume.
Other assignees with the most granted patents in TVI's primary technology class.
TVI's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
38 Top 42% higher than 58% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 1 | 6.7% |
| 2019 | 2 | 13.3% |
| 2020 | 3 | 20.0% |
| 2021 | 1 | 6.7% |
| 2022 | 3 | 20.0% |
| 2023 | 4 | 26.7% |
| 2024 | 1 | 6.7% |
Top 7 of 7 technology areas
Overall rank by patents
#19,290
of 49,997 tracked assignees
38.1 out of 100
What to do with this data
TVI Entwicklung & Produktion GMBH's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.